Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 269 entries
Sorted by: Best Match Show Resources per page
Synthesis and Evaluation of the Antibacterial Activities of 13-Substituted Berberine Derivatives.

Antibiotics (Basel, Switzerland)

Olleik H, Yacoub T, Hoffer L, Gnansounou SM, Benhaiem-Henry K, Nicoletti C, Mekhalfi M, Pique V, Perrier J, Hijazi A, Baydoun E, Raymond J, Piccerelle P, Maresca M, Robin M.
PMID: 32640578
Antibiotics (Basel). 2020 Jul 06;9(7). doi: 10.3390/antibiotics9070381.

The biological activities of berberine, a natural plant molecule, are known to be affected by structural modifications, mostly at position 9 and/or 13. A series of new 13-substituted berberine derivatives were synthesized and evaluated in term of antimicrobial activity...

Cite
Olleik H, Yacoub T, Hoffer L, et al. Synthesis and Evaluation of the Antibacterial Activities of 13-Substituted Berberine Derivatives. Antibiotics (Basel). 2020;9(7)doi: 10.3390/antibiotics9070381.
Olleik, H., Yacoub, T., Hoffer, L., Gnansounou, S. M., Benhaiem-Henry, K., Nicoletti, C., Mekhalfi, M., Pique, V., Perrier, J., Hijazi, A., Baydoun, E., Raymond, J., Piccerelle, P., Maresca, M., & Robin, M. (2020). Synthesis and Evaluation of the Antibacterial Activities of 13-Substituted Berberine Derivatives. Antibiotics (Basel, Switzerland), 9(7), . https://doi.org/10.3390/antibiotics9070381
Olleik, Hamza, et al. "Synthesis and Evaluation of the Antibacterial Activities of 13-Substituted Berberine Derivatives." Antibiotics (Basel, Switzerland) vol. 9,7 (2020). doi: https://doi.org/10.3390/antibiotics9070381
Olleik H, Yacoub T, Hoffer L, Gnansounou SM, Benhaiem-Henry K, Nicoletti C, Mekhalfi M, Pique V, Perrier J, Hijazi A, Baydoun E, Raymond J, Piccerelle P, Maresca M, Robin M. Synthesis and Evaluation of the Antibacterial Activities of 13-Substituted Berberine Derivatives. Antibiotics (Basel). 2020 Jul 06;9(7). doi: 10.3390/antibiotics9070381. PMID: 32640578; PMCID: PMC7400437.
Copy Download .nbib Format: NLM
Myristyltrimethylammonium Bromide (MYTAB) as a Cationic Surface Agent to Inhibit .

Journal of functional biomaterials

Mena Silva PA, Garcia IM, Nunes J, Visioli F, Castelo Branco Leitune V, Melo MA, Collares FM.
PMID: 32075267
J Funct Biomater. 2020 Feb 15;11(1). doi: 10.3390/jfb11010009.

This in vitro study evaluated the effect of myristyltrimethylammonium bromide (MYTAB) on the physical, chemical, and biological properties of an experimental dental resin. The resin was formulated with dental dimetacrylate monomers and a photoinitiator/co-initiator system. MYTAB was added at...

Cite
Mena Silva PA, Garcia IM, Nunes J, et al. Myristyltrimethylammonium Bromide (MYTAB) as a Cationic Surface Agent to Inhibit . J Funct Biomater. 2020;11(1)doi: 10.3390/jfb11010009.
Mena Silva, P. A., Garcia, I. M., Nunes, J., Visioli, F., Castelo Branco Leitune, V., Melo, M. A., & Collares, F. M. (2020). Myristyltrimethylammonium Bromide (MYTAB) as a Cationic Surface Agent to Inhibit . Journal of functional biomaterials, 11(1), . https://doi.org/10.3390/jfb11010009
Mena Silva, Paola Andrea, et al. "Myristyltrimethylammonium Bromide (MYTAB) as a Cationic Surface Agent to Inhibit ." Journal of functional biomaterials vol. 11,1 (2020). doi: https://doi.org/10.3390/jfb11010009
Mena Silva PA, Garcia IM, Nunes J, Visioli F, Castelo Branco Leitune V, Melo MA, Collares FM. Myristyltrimethylammonium Bromide (MYTAB) as a Cationic Surface Agent to Inhibit . J Funct Biomater. 2020 Feb 15;11(1). doi: 10.3390/jfb11010009. PMID: 32075267; PMCID: PMC7151596.
Copy Download .nbib Format: NLM
Association between Full Electronic Medical Record System Adoption and Drug Use: Antibiotics and Polypharmacy.

Healthcare informatics research

Park YT, Kim D, Park RW, Atalag K, Kwon IH, Yoon D, Choi M.
PMID: 32082702
Healthc Inform Res. 2020 Jan;26(1):68-77. doi: 10.4258/hir.2020.26.1.68. Epub 2020 Jan 31.

OBJECTIVES: We investigated associations between full Electronic Medical Record (EMR) system adoption and drug use in healthcare organizations (HCOs) to explore whether EMR system features such as electronic prescribing, medicines reconciliation, and decision support, might be related to drug...

Cite
Park YT, Kim D, Park RW, et al. Association between Full Electronic Medical Record System Adoption and Drug Use: Antibiotics and Polypharmacy. Healthc Inform Res. 2020;26(1):68-77doi: 10.4258/hir.2020.26.1.68.
Park, Y. T., Kim, D., Park, R. W., Atalag, K., Kwon, I. H., Yoon, D., & Choi, M. (2020). Association between Full Electronic Medical Record System Adoption and Drug Use: Antibiotics and Polypharmacy. Healthcare informatics research, 26(1), 68-77. https://doi.org/10.4258/hir.2020.26.1.68
Park, Young-Taek, et al. "Association between Full Electronic Medical Record System Adoption and Drug Use: Antibiotics and Polypharmacy." Healthcare informatics research vol. 26,1 (2020): 68-77. doi: https://doi.org/10.4258/hir.2020.26.1.68
Park YT, Kim D, Park RW, Atalag K, Kwon IH, Yoon D, Choi M. Association between Full Electronic Medical Record System Adoption and Drug Use: Antibiotics and Polypharmacy. Healthc Inform Res. 2020 Jan;26(1):68-77. doi: 10.4258/hir.2020.26.1.68. Epub 2020 Jan 31. PMID: 32082702; PMCID: PMC7010944.
Copy Download .nbib Format: NLM
Antimicrobial Stewardship: From Bedside to Theory. Thirteen Examples of Old and More Recent Strategies from Everyday Clinical Practice.

Antibiotics (Basel, Switzerland)

Di Bella S, Beović B, Fabbiani M, Valentini M, Luzzati R.
PMID: 32664288
Antibiotics (Basel). 2020 Jul 10;9(7). doi: 10.3390/antibiotics9070398.

"Antimicrobial stewardship" is a strategy that promotes the responsible use of antimicrobials. The objective of this paper is to focus on consolidated and more recent improvements in clinical strategies that should be adopted in hospitalized patients to ameliorate their...

Cite
Di Bella S, Beović B, Fabbiani M, et al. Antimicrobial Stewardship: From Bedside to Theory. Thirteen Examples of Old and More Recent Strategies from Everyday Clinical Practice. Antibiotics (Basel). 2020;9(7)doi: 10.3390/antibiotics9070398.
Di Bella, S., Beović, B., Fabbiani, M., Valentini, M., & Luzzati, R. (2020). Antimicrobial Stewardship: From Bedside to Theory. Thirteen Examples of Old and More Recent Strategies from Everyday Clinical Practice. Antibiotics (Basel, Switzerland), 9(7), . https://doi.org/10.3390/antibiotics9070398
Di Bella, Stefano, et al. "Antimicrobial Stewardship: From Bedside to Theory. Thirteen Examples of Old and More Recent Strategies from Everyday Clinical Practice." Antibiotics (Basel, Switzerland) vol. 9,7 (2020). doi: https://doi.org/10.3390/antibiotics9070398
Di Bella S, Beović B, Fabbiani M, Valentini M, Luzzati R. Antimicrobial Stewardship: From Bedside to Theory. Thirteen Examples of Old and More Recent Strategies from Everyday Clinical Practice. Antibiotics (Basel). 2020 Jul 10;9(7). doi: 10.3390/antibiotics9070398. PMID: 32664288; PMCID: PMC7399849.
Copy Download .nbib Format: NLM
Culture of antibiotic use in Kosovo - an interview study with patients and health professionals.

Pharmacy practice

Jakupi A, Raka D, Kaae S, Sporrong SK.
PMID: 31592295
Pharm Pract (Granada). 2019 Jul-Sep;17(3):1540. doi: 10.18549/PharmPract.2019.3.1540. Epub 2019 Aug 22.

BACKGROUND: Kosovo is a new state and has a high consumption of antibiotics in relation to other European countries. Existing quantitative studies have shown that practices exist that is not optimal when it comes to antibiotic use in Kosovo,...

Cite
Jakupi A, Raka D, Kaae S, et al. Culture of antibiotic use in Kosovo - an interview study with patients and health professionals. Pharm Pract (Granada). 2019;17(3):1540doi: 10.18549/PharmPract.2019.3.1540.
Jakupi, A., Raka, D., Kaae, S., & Sporrong, S. K. (2019). Culture of antibiotic use in Kosovo - an interview study with patients and health professionals. Pharmacy practice, 17(3), 1540. https://doi.org/10.18549/PharmPract.2019.3.1540
Jakupi, Arianit, et al. "Culture of antibiotic use in Kosovo - an interview study with patients and health professionals." Pharmacy practice vol. 17,3 (2019): 1540. doi: https://doi.org/10.18549/PharmPract.2019.3.1540
Jakupi A, Raka D, Kaae S, Sporrong SK. Culture of antibiotic use in Kosovo - an interview study with patients and health professionals. Pharm Pract (Granada). 2019 Jul-Sep;17(3):1540. doi: 10.18549/PharmPract.2019.3.1540. Epub 2019 Aug 22. PMID: 31592295; PMCID: PMC6763296.
Copy Download .nbib Format: NLM
Oral prednisolone for acute otitis media in children: a pilot, pragmatic, randomised, open-label, controlled study (OPAL study).

Pilot and feasibility studies

Ranakusuma RW, McCullough AR, Safitri ED, Pitoyo Y, Widyaningsih W, Del Mar CB, Beller EM.
PMID: 32874679
Pilot Feasibility Stud. 2020 Aug 29;6:121. doi: 10.1186/s40814-020-00671-5. eCollection 2020.

BACKGROUND: Acute otitis media (AOM) is associated with high antibiotic prescribing rates. Antibiotics are somewhat effective in improving pain and middle ear effusion (MEE); however, they have unfavourable effects. Alternative treatments, such as corticosteroids as anti-inflammatory agents, are needed....

Cite
Ranakusuma RW, McCullough AR, Safitri ED, et al. Oral prednisolone for acute otitis media in children: a pilot, pragmatic, randomised, open-label, controlled study (OPAL study). Pilot Feasibility Stud. 2020;6:121doi: 10.1186/s40814-020-00671-5.
Ranakusuma, R. W., McCullough, A. R., Safitri, E. D., Pitoyo, Y., Widyaningsih, W., Del Mar, C. B., & Beller, E. M. (2020). Oral prednisolone for acute otitis media in children: a pilot, pragmatic, randomised, open-label, controlled study (OPAL study). Pilot and feasibility studies, 6121. https://doi.org/10.1186/s40814-020-00671-5
Ranakusuma, Respati W, et al. "Oral prednisolone for acute otitis media in children: a pilot, pragmatic, randomised, open-label, controlled study (OPAL study)." Pilot and feasibility studies vol. 6 (2020): 121. doi: https://doi.org/10.1186/s40814-020-00671-5
Ranakusuma RW, McCullough AR, Safitri ED, Pitoyo Y, Widyaningsih W, Del Mar CB, Beller EM. Oral prednisolone for acute otitis media in children: a pilot, pragmatic, randomised, open-label, controlled study (OPAL study). Pilot Feasibility Stud. 2020 Aug 29;6:121. doi: 10.1186/s40814-020-00671-5. eCollection 2020. PMID: 32874679; PMCID: PMC7455987.
Copy Download .nbib Format: NLM
Neonatal sepsis registry: Time to antibiotic dataset.

Data in brief

Ostapenko S, Schmatz M, Srinivasan L, Elci OU, Weiss SL, Masino AJ, Tremoglie M, Harris MC, Grundmeier RW.
PMID: 31799346
Data Brief. 2019 Nov 11;27:104788. doi: 10.1016/j.dib.2019.104788. eCollection 2019 Dec.

This article describes the process of extracting electronic health record (EHR) data into a format that supports analyses related to the timeliness of antibiotic administration. The de-identified data that accompanies this article were collected from a cohort of infants...

Cite
Ostapenko S, Schmatz M, Srinivasan L, et al. Neonatal sepsis registry: Time to antibiotic dataset. Data Brief. 2019;27:104788doi: 10.1016/j.dib.2019.104788.
Ostapenko, S., Schmatz, M., Srinivasan, L., Elci, O. U., Weiss, S. L., Masino, A. J., Tremoglie, M., Harris, M. C., & Grundmeier, R. W. (2019). Neonatal sepsis registry: Time to antibiotic dataset. Data in brief, 27104788. https://doi.org/10.1016/j.dib.2019.104788
Ostapenko, Svetlana, et al. "Neonatal sepsis registry: Time to antibiotic dataset." Data in brief vol. 27 (2019): 104788. doi: https://doi.org/10.1016/j.dib.2019.104788
Ostapenko S, Schmatz M, Srinivasan L, Elci OU, Weiss SL, Masino AJ, Tremoglie M, Harris MC, Grundmeier RW. Neonatal sepsis registry: Time to antibiotic dataset. Data Brief. 2019 Nov 11;27:104788. doi: 10.1016/j.dib.2019.104788. eCollection 2019 Dec. PMID: 31799346; PMCID: PMC6881601.
Copy Download .nbib Format: NLM
Targeted Combination Antibiotic Therapy Induces Remission in Treatment-Naïve Crohn's Disease: A Case Series.

Microorganisms

Agrawal G, Clancy A, Sharma R, Huynh R, Ramrakha S, Borody T.
PMID: 32155771
Microorganisms. 2020 Mar 06;8(3). doi: 10.3390/microorganisms8030371.

Prospective trials of anti-mycobacterial antibiotic therapy (AMAT) have proven efficacious in Crohn's disease (CD) but use as first-line treatment in CD has not been evaluated. This paper reports the outcomes of patients with CD treated with first-line AMAT. This...

Cite
Agrawal G, Clancy A, Sharma R, et al. Targeted Combination Antibiotic Therapy Induces Remission in Treatment-Naïve Crohn's Disease: A Case Series. Microorganisms. 2020;8(3)doi: 10.3390/microorganisms8030371.
Agrawal, G., Clancy, A., Sharma, R., Huynh, R., Ramrakha, S., & Borody, T. (2020). Targeted Combination Antibiotic Therapy Induces Remission in Treatment-Naïve Crohn's Disease: A Case Series. Microorganisms, 8(3), . https://doi.org/10.3390/microorganisms8030371
Agrawal, Gaurav, et al. "Targeted Combination Antibiotic Therapy Induces Remission in Treatment-Naïve Crohn's Disease: A Case Series." Microorganisms vol. 8,3 (2020). doi: https://doi.org/10.3390/microorganisms8030371
Agrawal G, Clancy A, Sharma R, Huynh R, Ramrakha S, Borody T. Targeted Combination Antibiotic Therapy Induces Remission in Treatment-Naïve Crohn's Disease: A Case Series. Microorganisms. 2020 Mar 06;8(3). doi: 10.3390/microorganisms8030371. PMID: 32155771; PMCID: PMC7142403.
Copy Download .nbib Format: NLM
MAC Attack: Clinical Correlates of .

Journal of clinical medicine research

Gupta K, Feinstein MB, Goldman DA, Patail HS, Stover DE.
PMID: 32231749
J Clin Med Res. 2020 Mar;12(3):142-149. doi: 10.14740/jocmr4058. Epub 2020 Mar 02.

BACKGROUND: In 2007 the American Thoracic Society (ATS) released guidelines on management of METHODS: We retrospectively analyzed 550 adult, non-human immunodeficiency virus (HIV) patients, among whom MAC was identified in respiratory cultures or tissue. Radiographs, clinical symptoms and cancer...

Cite
Gupta K, Feinstein MB, Goldman DA, et al. MAC Attack: Clinical Correlates of . J Clin Med Res. 2020;12(3):142-149doi: 10.14740/jocmr4058.
Gupta, K., Feinstein, M. B., Goldman, D. A., Patail, H. S., & Stover, D. E. (2020). MAC Attack: Clinical Correlates of . Journal of clinical medicine research, 12(3), 142-149. https://doi.org/10.14740/jocmr4058
Gupta, Karan, et al. "MAC Attack: Clinical Correlates of ." Journal of clinical medicine research vol. 12,3 (2020): 142-149. doi: https://doi.org/10.14740/jocmr4058
Gupta K, Feinstein MB, Goldman DA, Patail HS, Stover DE. MAC Attack: Clinical Correlates of . J Clin Med Res. 2020 Mar;12(3):142-149. doi: 10.14740/jocmr4058. Epub 2020 Mar 02. PMID: 32231749; PMCID: PMC7092760.
Copy Download .nbib Format: NLM
Trends in Systemic Antibiotic Therapy of Endodontic Infections: a Survey among Dental Practitioners in Lithuania.

Journal of oral & maxillofacial research

Mende A, Venskutonis T, Mackeviciute M.
PMID: 32377326
J Oral Maxillofac Res. 2020 Mar 31;11(1):e2. doi: 10.5037/jomr.2020.11102. eCollection 2020.

OBJECTIVES: Prescription trends to certain antibiotic classes in Lithuania have been observed. Considering the potential contribution to antimicrobial resistance and the evidence of inappropriate prescriptions highlights, the periodical assessment of antibiotic consumption trends is required. The aim of this...

Cite
Mende A, Venskutonis T, Mackeviciute M. Trends in Systemic Antibiotic Therapy of Endodontic Infections: a Survey among Dental Practitioners in Lithuania. J Oral Maxillofac Res. 2020;11(1):e2doi: 10.5037/jomr.2020.11102.
Mende, A., Venskutonis, T., & Mackeviciute, M. (2020). Trends in Systemic Antibiotic Therapy of Endodontic Infections: a Survey among Dental Practitioners in Lithuania. Journal of oral & maxillofacial research, 11(1), e2. https://doi.org/10.5037/jomr.2020.11102
Mende, Alexander, et al. "Trends in Systemic Antibiotic Therapy of Endodontic Infections: a Survey among Dental Practitioners in Lithuania." Journal of oral & maxillofacial research vol. 11,1 (2020): e2. doi: https://doi.org/10.5037/jomr.2020.11102
Mende A, Venskutonis T, Mackeviciute M. Trends in Systemic Antibiotic Therapy of Endodontic Infections: a Survey among Dental Practitioners in Lithuania. J Oral Maxillofac Res. 2020 Mar 31;11(1):e2. doi: 10.5037/jomr.2020.11102. eCollection 2020. PMID: 32377326; PMCID: PMC7191382.
Copy Download .nbib Format: NLM
The rate of antibiotic utilization in Iranian under 5-year-old children with acute respiratory tract illness: A nationwide community-based study.

Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences

Mostafavi N, Rashidian A, Karimi-Shahanjarini A, Khosravi A, Kelishadi R.
PMID: 26487870
J Res Med Sci. 2015 May;20(5):429-33. doi: 10.4103/1735-1995.163952.

BACKGROUND: To investigate the prevalence of antibiotic usage in children aged

Cite
Mostafavi N, Rashidian A, Karimi-Shahanjarini A, et al. The rate of antibiotic utilization in Iranian under 5-year-old children with acute respiratory tract illness: A nationwide community-based study. J Res Med Sci. 2015;20(5):429-33doi: 10.4103/1735-1995.163952.
Mostafavi, N., Rashidian, A., Karimi-Shahanjarini, A., Khosravi, A., & Kelishadi, R. (2015). The rate of antibiotic utilization in Iranian under 5-year-old children with acute respiratory tract illness: A nationwide community-based study. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 20(5), 429-33. https://doi.org/10.4103/1735-1995.163952
Mostafavi, Nasser, et al. "The rate of antibiotic utilization in Iranian under 5-year-old children with acute respiratory tract illness: A nationwide community-based study." Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences vol. 20,5 (2015): 429-33. doi: https://doi.org/10.4103/1735-1995.163952
Mostafavi N, Rashidian A, Karimi-Shahanjarini A, Khosravi A, Kelishadi R. The rate of antibiotic utilization in Iranian under 5-year-old children with acute respiratory tract illness: A nationwide community-based study. J Res Med Sci. 2015 May;20(5):429-33. doi: 10.4103/1735-1995.163952. PMID: 26487870; PMCID: PMC4590196.
Copy Download .nbib Format: NLM
[The current situation, problems and management strategies of antimicrobial resistance in medical field].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]

Xia ZF, Li JQ.
PMID: 29747335
Zhonghua Yu Fang Yi Xue Za Zhi. 2018 May 06;52(5):460-463. doi: 10.3760/cma.j.issn.0253-9624.2018.05.002.

No abstract available.

Cite
Xia ZF, Li JQ. [The current situation, problems and management strategies of antimicrobial resistance in medical field]. Zhonghua Yu Fang Yi Xue Za Zhi. 2018;52(5):460-463doi: 10.3760/cma.j.issn.0253-9624.2018.05.002.
Xia, Z. F., & Li, J. Q. (2018). [The current situation, problems and management strategies of antimicrobial resistance in medical field]. Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine], 52(5), 460-463. https://doi.org/10.3760/cma.j.issn.0253-9624.2018.05.002
Xia, Z F, and Li, J Q. "[The current situation, problems and management strategies of antimicrobial resistance in medical field]." Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] vol. 52,5 (2018): 460-463. doi: https://doi.org/10.3760/cma.j.issn.0253-9624.2018.05.002
Xia ZF, Li JQ. [The current situation, problems and management strategies of antimicrobial resistance in medical field]. Zhonghua Yu Fang Yi Xue Za Zhi. 2018 May 06;52(5):460-463. doi: 10.3760/cma.j.issn.0253-9624.2018.05.002. Chinese. PMID: 29747335.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 269 entries